In this free webinar, learn how to validate R for clinical use while maintaining appropriate controls. The featured speakers will discuss how R and SAS can be usedIn this free webinar, learn how to validate R for clinical use while maintaining appropriate controls. The featured speakers will discuss how R and SAS can be used

How to Safely Harness R and SAS for Cutting-Edge and Validated Clinical Analytics, Upcoming Webinar Hosted by Xtalks

3 min read

In this free webinar, learn how to validate R for clinical use while maintaining appropriate controls. The featured speakers will discuss how R and SAS can be used together without undermining auditability and traceability. Attendees will gain insight into practical governance steps to manage package updates, versioning and reproducibility. The speakers will also discuss how validation practices support compliant clinical analytics outputs.

TORONTO, Feb. 5, 2026 /PRNewswire/ — Life sciences companies face increasing pressure to expand clinical analytics beyond traditional SAS workflows to support more flexible analyses, richer visualizations and faster access to evolving statistical methods. Using open-source languages such as R alongside the commercial SAS language provides access to distinct capabilities and methodologies enabled by the rapid evolution of open-source technology. This webinar will explore how to adopt R alongside SAS while maintaining the validation controls required for compliant clinical use.

With frequent changes and the ability for anyone to contribute, open-source languages rapidly evolve. However, these also introduce significant challenges for validation, a critical component of any technology used for the development and analysis of clinical data.

In this webinar, the featured speakers will outline a practical approach to validating R as an open-source technology. With this approach, attendees will be able to balance rapid adoption of evolving open-source technologies with appropriate controls to ensure that analytic outputs are valid and compliant for clinical use.

Register for this webinar to learn how clinical analytics can be validated when R and SAS are used together for compliant clinical data analysis.

Join experts from d-wise, an Instem Company, Phil Loucks, Commercial Director; and Jonathon Hollahan, Deputy General Manager, for the live webinar on Thursday, February 26, 2026, at 2pm EST (11am PST).

For more information, or to register for this event, visit How to Safely Harness R and SAS for Cutting-Edge and Validated Clinical Analytics.

ABOUT XTALKS

Xtalks — The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what’s next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/how-to-safely-harness-r-and-sas-for-cutting-edge-and-validated-clinical-analytics-upcoming-webinar-hosted-by-xtalks-302679005.html

SOURCE Xtalks

Market Opportunity
Edge Logo
Edge Price(EDGE)
$0.09
$0.09$0.09
-7.11%
USD
Edge (EDGE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

Woman shot 5 times by DHS to stare down Trump at State of the Union address

Woman shot 5 times by DHS to stare down Trump at State of the Union address

A House Democrat has invited Marimar Martinez to attend President Donald Trump's State of the Union address in Washington, D.C., after she was shot by Customs and
Share
Rawstory2026/02/06 03:36
CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

CEO Sandeep Nailwal Shared Highlights About RWA on Polygon

The post CEO Sandeep Nailwal Shared Highlights About RWA on Polygon appeared on BitcoinEthereumNews.com. Polygon CEO Sandeep Nailwal highlighted Polygon’s lead in global bonds, Spiko US T-Bill, and Spiko Euro T-Bill. Polygon published an X post to share that its roadmap to GigaGas was still scaling. Sentiments around POL price were last seen to be bearish. Polygon CEO Sandeep Nailwal shared key pointers from the Dune and RWA.xyz report. These pertain to highlights about RWA on Polygon. Simultaneously, Polygon underlined its roadmap towards GigaGas. Sentiments around POL price were last seen fumbling under bearish emotions. Polygon CEO Sandeep Nailwal on Polygon RWA CEO Sandeep Nailwal highlighted three key points from the Dune and RWA.xyz report. The Chief Executive of Polygon maintained that Polygon PoS was hosting RWA TVL worth $1.13 billion across 269 assets plus 2,900 holders. Nailwal confirmed from the report that RWA was happening on Polygon. The Dune and https://t.co/W6WSFlHoQF report on RWA is out and it shows that RWA is happening on Polygon. Here are a few highlights: – Leading in Global Bonds: Polygon holds 62% share of tokenized global bonds (driven by Spiko’s euro MMF and Cashlink euro issues) – Spiko U.S.… — Sandeep | CEO, Polygon Foundation (※,※) (@sandeepnailwal) September 17, 2025 The X post published by Polygon CEO Sandeep Nailwal underlined that the ecosystem was leading in global bonds by holding a 62% share of tokenized global bonds. He further highlighted that Polygon was leading with Spiko US T-Bill at approximately 29% share of TVL along with Ethereum, adding that the ecosystem had more than 50% share in the number of holders. Finally, Sandeep highlighted from the report that there was a strong adoption for Spiko Euro T-Bill with 38% share of TVL. He added that 68% of returns were on Polygon across all the chains. Polygon Roadmap to GigaGas In a different update from Polygon, the community…
Share
BitcoinEthereumNews2025/09/18 01:10
WLFI Drops 20% Weekly as Price Tests the Crucial $0.113 Support

WLFI Drops 20% Weekly as Price Tests the Crucial $0.113 Support

On Thursday, February 5, World Liberty Financial (WLFI) is continuing its decline and is trading at $0.1281, decreased by 5.89% in the past day. The token has lost
Share
Tronweekly2026/02/06 03:00